These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27692470)

  • 1. Complement activation by cholesterol crystals triggers a subsequent cytokine response.
    Niyonzima N; Halvorsen B; Sporsheim B; Garred P; Aukrust P; Mollnes TE; Espevik T
    Mol Immunol; 2017 Apr; 84():43-50. PubMed ID: 27692470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.
    Samstad EO; Niyonzima N; Nymo S; Aune MH; Ryan L; Bakke SS; Lappegård KT; Brekke OL; Lambris JD; Damås JK; Latz E; Mollnes TE; Espevik T
    J Immunol; 2014 Mar; 192(6):2837-45. PubMed ID: 24554772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol Crystals Activate the Lectin Complement Pathway via Ficolin-2 and Mannose-Binding Lectin: Implications for the Progression of Atherosclerosis.
    Pilely K; Rosbjerg A; Genster N; Gal P; Pál G; Halvorsen B; Holm S; Aukrust P; Bakke SS; Sporsheim B; Nervik I; Niyonzima N; Bartels ED; Stahl GL; Mollnes TE; Espevik T; Garred P
    J Immunol; 2016 Jun; 196(12):5064-74. PubMed ID: 27183610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
    Niyonzima N; Bakke SS; Gregersen I; Holm S; Sandanger Ø; Orrem HL; Sporsheim B; Ryan L; Kong XY; Dahl TB; Skjelland M; Sørensen KK; Rokstad AM; Yndestad A; Latz E; Gullestad L; Andersen GØ; Damås JK; Aukrust P; Mollnes TE; Halvorsen B; Espevik T
    EBioMedicine; 2020 Oct; 60():102985. PubMed ID: 32927275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation.
    Thacker SG; Zarzour A; Chen Y; Alcicek MS; Freeman LA; Sviridov DO; Demosky SJ; Remaley AT
    Immunology; 2016 Nov; 149(3):306-319. PubMed ID: 27329564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation.
    Bakke SS; Aune MH; Niyonzima N; Pilely K; Ryan L; Skjelland M; Garred P; Aukrust P; Halvorsen B; Latz E; Damås JK; Mollnes TE; Espevik T
    J Immunol; 2017 Oct; 199(8):2910-2920. PubMed ID: 28855312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstituted High-Density Lipoprotein Attenuates Cholesterol Crystal-Induced Inflammatory Responses by Reducing Complement Activation.
    Niyonzima N; Samstad EO; Aune MH; Ryan L; Bakke SS; Rokstad AM; Wright SD; Damås JK; Mollnes TE; Latz E; Espevik T
    J Immunol; 2015 Jul; 195(1):257-64. PubMed ID: 26026058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.
    Freigang S; Ampenberger F; Spohn G; Heer S; Shamshiev AT; Kisielow J; Hersberger M; Yamamoto M; Bachmann MF; Kopf M
    Eur J Immunol; 2011 Jul; 41(7):2040-51. PubMed ID: 21484785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: A potential new compound for treatment of atherosclerosis.
    Pilely K; Bakke SS; Palarasah Y; Skjoedt MO; Bartels ED; Espevik T; Garred P
    Atherosclerosis; 2019 Apr; 283():35-42. PubMed ID: 30772772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inflammasome activation by Porphyromonas gingivalis and cholesterol crystals in human macrophages and coronary artery endothelial cells.
    Champaiboon C; Poolgesorn M; Wisitrasameewong W; Sa-Ard-Iam N; Rerkyen P; Mahanonda R
    Atherosclerosis; 2014 Jul; 235(1):38-44. PubMed ID: 24814648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis.
    Warnatsch A; Ioannou M; Wang Q; Papayannopoulos V
    Science; 2015 Jul; 349(6245):316-20. PubMed ID: 26185250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue Factor.
    Gravastrand CS; Steinkjer B; Halvorsen B; Landsem A; Skjelland M; Jacobsen EA; Woodruff TM; Lambris JD; Mollnes TE; Brekke OL; Espevik T; Rokstad AMA
    J Immunol; 2019 Aug; 203(4):853-863. PubMed ID: 31270150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages.
    Donat C; Thanei S; Trendelenburg M
    Front Immunol; 2019; 10():2712. PubMed ID: 31824501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis: perspectives of anti-inflammatory therapy.
    Nasonov EL; Popkova TV
    Ter Arkh; 2018 May; 90(5):4-12. PubMed ID: 30701884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells.
    Mezzasoma L; Antognelli C; Talesa VN
    Immunol Res; 2016 Feb; 64(1):303-12. PubMed ID: 26616294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis.
    Hovland A; Jonasson L; Garred P; Yndestad A; Aukrust P; Lappegård KT; Espevik T; Mollnes TE
    Atherosclerosis; 2015 Aug; 241(2):480-94. PubMed ID: 26086357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP3 is Required for Complement-Mediated Caspase-1 and IL-1beta Activation in ICH.
    Yao ST; Cao F; Chen JL; Chen W; Fan RM; Li G; Zeng YC; Jiao S; Xia XP; Han C; Ran QS
    J Mol Neurosci; 2017 Mar; 61(3):385-395. PubMed ID: 27933491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C5a potentiates uric acid crystal-induced IL-1β production.
    An LL; Mehta P; Xu L; Turman S; Reimer T; Naiman B; Connor J; Sanjuan M; Kolbeck R; Fung M
    Eur J Immunol; 2014 Dec; 44(12):3669-79. PubMed ID: 25229885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.